The effect of basal insulin glargine on the fibrinolytic system and von Willebrand factor in people with dysglycaemia and high risk for cardiovascular events: Swedish substudy of the Outcome Reduction with an Initial Glargine Intervention trial

Aslak Rautio, Kurt Boman, Hertzel C Gerstein, Jenny Hernestål-Boman, Shun Fu Lee, Mona Olofsson, Linda Garcia Mellbin
  • Diabetes and Vascular Disease Research, April 2017, SAGE Publishing
  • DOI: 10.1177/1479164117703034
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Aslak Rautio